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Abstract
Background: Familial atrial fibrillation, an autosomal dominant disease, was previously mapped to
chromosome 10q22. One of the genes mapped to the 10q22 region is DLG5, a member of the
MAGUKs (Membrane Associated Gyanylate Kinase) family which mediates intracellular signaling.
Only a partial cDNA was available for DLG5. To exclude potential disease inducing mutations, it
was necessary to obtain a complete cDNA and genomic sequence of the gene.
Methods: The Northern Blot analysis performed using 3' UTR of this gene indicated the transcript
size to be about 7.2 KB. Using race technique and library screening the entire cDNA was cloned.
This gene was evaluated by sequencing the coding region and splice functions in normal and affected
family members with familial atrial fibrillation. Furthermore, haploid cell lines from affected patients
were generated and analyzed for deletions that may have been missed by PCR.
Results: We identified two distinct alternately spliced transcripts of this gene. The genomic
sequence of the DLG5 gene spanned 79 KB with 32 exons and was shown to have ubiquitous
human tissue expression including placenta, heart, skeletal muscle, liver and pancreas.
Conclusions: The entire cDNA of DLG5 was identified, sequenced and its genomic organization
determined.
Background
Atrial fibrillation is a chaotic atrial rhythm resulting from
abnormal signal generation and conduction in the atria.
The molecular basis for atrial fibrillation remains un-
known. It usually occurs in association with structural or
metabolic abnormalities. Atrial fibrillation, however,
does occur in individuals with none of these causes, re-
ferred to as lone atrial fibrillation. Recently, we identified
several families of multiple generations affected with atri-
al fibrillation with no other underlying cause detected.
This subset of familial atrial fibrillation provides an op-
portunity to explore a molecular basis for atrial fibrilla-
tion.
Atrial fibrillation segregates as an autosomal dominant
disease characterized by atrial fibrillation on an electro-
cardiogram [1]. We diagnosed atrial fibrillation in five
families from Spain in which the arrhythmia was the pri-
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mary manifestation and not associated with any gross car-
diac or metabolic abnormality [1]. Genetic linkage
analysis was performed and the locus responsible for atri-
al fibrillation in our family was mapped to 10q22 be-
tween markers D101786 and D10S1630, an area of about
11 cM [1]. We proceeded with the candidate gene ap-
proach and DLG5 was on of the genes mapped to the crit-
ical region between the flanking markers [2]. This gene
belongs to the MAGUK (Membrane Associated Gyanylate
Kinase) family of proteins known to form scaffolds for
proteins involved in intracellular signal transduction [2].
The MAGUK family of proteins has been extensively stud-
ied in recent years and shown to play a role in the forma-
tion of cell junctions, maintenance of cell shape, [3–5]
and clustering of channel proteins at the cell surface [6–
8]. Given its location in our critical region and its function
it was selected as a candidate for atrial fibrillation. A par-
tial cDNA sequence of DLG5 (GenBank accession
#AB011155) of about 5.3 K B was available. To determine
if there is a mutation responsible for the disease, it is nec-
essary to have the complete cDNA. Furthermore, recogniz-
ing that the responsible mutation may be present in one
of the intron-exon splice junctions, it is also necessary to
obtain the corresponding genomic sequence. Thus, we
cloned and sequenced the cDNA of the DLG5 gene and,
from the complete cDNA sequence, determined the in-
tron-exon boundaries of the gene as well as its human tis-
sue expression profile.
Materials And Methods
Northern blot analysis
The ESTym59b11 (ATCC clone #409942) clone was con-
firmed by sequencing a part of exon 31 and exon 32 with
the 3' untranslated region of the DLG5 cDNA. It was used
as a probe, labeled with the random primer labeling kit
from Gibco with 32P-dCTP and hybridized to an adult
multi tissue RNA blot from Clontech. Pre hybridization
and hybridization were performed with Express Hyb. So-
lution (Clontech) using the manufacturer's protocol. The
membrane was washed once with 2X SSC/0.1% SDS for
15 minutes at room temperature and twice in 0.2%X SSC/
0.1% SDS for 20 minutes at 68 C°. Membranes were ex-
posed to X-ray film (Kodak) overnight at -80 C.
Cloning and sequencing of the cDNA for DLG5
Using the RACE technique (Clontech, Marathon Ready
Heart cDNA) as per manufacturer's protocol, products
were generated using primers designed in the 5' end of the
described cDNA DLG5. Nested RACE was performed on
the product and the generated PCR product cloned by us-
ing TA cloning (Invitrogen). The clones were plated on
kanamycin IPTG plates. Colonies were picked and grown
in 5 ml LB-Kan broth. Subsequent to miniprep using Qia-
gen Miniprep Kit (QIAgen, Valencia, CA), the clones were
sequenced on the ABI310 genetic analyzer using the Big
Dye terminator chemistry. The Race primers are: Primer A
5' GCATACACTCCATTCTCCAGACTGATGC 3'; primer B
(nested to primer A) 5'CACTCATGATGAGCTTG-
TACTCGCTGTA 3'; primer F 5'GTGTGGTAGAAGT-
CAGTCTCCTTGGCCA 3';primer E (nested to primer F)
and 5'GCTGAATGGAGAGGTTCTCCACCTTCTC 3. We
generated additional 1.702 KB of cDNA for this gene for a
total cDNA length of 7.194 KB. The cDNA generated had
an overlap of 305 bp with the published DLG5 cDNA
(Genbank Acc. #AB011155) in the 5' end of the gene. We
further cloned, in two pieces with an overlap of 226 bp,
the cDNA covering about 2 Kb of this gene in the 5' end
from bp 1–2007 of the cDNA. The clones were: Clone T/F
1–471 bp of 7.194 Kb cDNA [using primers T 5' GGTCT-
CAACTTAAACTCCAGCACCACGA 3' with the primer F]
and clone G/A 246–2007 bp of 7.194 Kb cDNA [using
primer G 5' GAGAAGGTGGAG AACCTCTCCATTCAGC 3'
with primer A]. As mentioned there is an overlap of 226
bp (246–471 bp of 7.194 KB cDNA) between the two
clones. We performed multiple RACE reactions using
heart and placental cDNA until no further extension was
made to the cDNA suggesting we had reached the end of
the gene.
In addition to RACE, we also used PCR based heart library
screening (Origene Technologies, Cat#1001). We isolated
a clone that matched our RACE clone which gave confir-
mation to the cDNA sequence generated by the RACE
technique. We used Sequencer 3.1 program to assemble
our sequences. There was considerable overlap between
the 305 bp fragment of the new sequence and that of the
published cDNA of DLG5. We identified an ORF with a
stop codon preceding it indicating we had obtained the
entire coding region of the gene. The complete cDNA se-
quence has been submitted to Genbank, Accession
Number AF352034.
In-Silicon mapping and genomic organisation Of DLG5
The newly generated DLG5 cDNA sequence (7.195 Kb)
was subjected to a search for homology to genomic se-
quences in Genbank using BLASTN algorithm on Search
Launcher, available at Molecular Biology Computational
Resources (MBCR) server, Baylor College of Medicine
(BCM)  [www.mbcr.bcm.tmc.edu] . Homologous se-
quences were identified on BAC 651 c23 (Acc. No.
AC013252) and BAC 126h7 (Acc. No. AL391421). The
Sequencer 3.1 program was employed to assemble ge-
nomic sequences from these BACs and to map the cDNA
to these sequences. The genomic sequences for the gene
were deposited in GenBank with Accession Number
AF352033.
Analysis of patient DNA
Using available genomic sequences, primers were de-
signed to analyze the patient DNA. Primers were anchoredBMC Genomics 2002, 3 http://www.biomedcentral.com/1471-2164/3/6
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in introns and PCR products generated from genomic
DNA of patients. PCR was performed with 200 ng genom-
ic DNA, 50 µM each deoxynucleotide triphosphate, 02 µM
of forward and reverse primers each and 2.5 units of Taq
Polymerase (life Technologies). PCR was done on PE9600
or PE9700 thermocycler. Sequencing reactions were per-
formed using fluorescent labeled Big Dye terminator (Ap-
plied Biosystems, Foster City, CA) on a PE9600
thermocycler. Each reaction was then cleaned over the
Edge Biosystems column and subsequently sequenced on
an ABI310 or ABI377 genetic analyzer. Sequences were as-
sembled using Sequencer 3.1 program.
Use of a novel technique to rule out deletion mutations
We utilized a newly available somatic cell hybrid tech-
nique from GMP Genetics, Inc. [9] to obtain haploid cell
lines. In brief, this technology provides a means whereby
the two homologous chromosomes are separated and iso-
lated into separate cell lines. Our affected patient's diploid
leucocytic cell line was converted to haploid somatic cell
hybrid lines. The hybrid cell lines were screened to identi-
fy those cell lines that contain the chromosome 10 homo-
logues. We further confirmed by genotyping that the DNA
of one of these haploid lines had the alleles segregating
with the disease. Thus, if a mutation in the DLG5 gene is
responsible for the disease it would be in this cell line. We
then performed PCR using primers anchored in the in-
trons of DLG5 for each of the exons on both the normal
haploid DNA and the disease bearing haploid DNA. The
presence of amplification products from both haploid
lines would detect any exon deletion that may have elud-
ed detection by PCR from genomic DNA.
Results and discussion
We previously mapped the locus for familial atrial fibril-
lation to 10q22-24 between markers D10S1694 and
D10S1786. In the NCBI database DLG5 had been
mapped to 10q22. We subsequently mapped the entire
cDNA on to genomic sequences from BACs RPII651C23 &
RPII126H7, which also have the marker D10S569 that lies
between our flanking markers. Thus DLG5 lies within our
critical region at 10q22 within 100 KB of D10s569.
Human tissue expression patterns of DLG5
The expression pattern of the DLG5 gene was analyzed in
multiple adult human tissues by Northern Blot Analysis
using as a probe the ATCC clone #409942 (EST ym59b11)
with insert an size of 2.386 Kb which contains exon 31
and 32 with 3' untranslated region of the gene. A twenty-
four hour exposure showed abundant expression in pla-
centa with minimal expression in skeletal muscle, liver,
kidney and pancreas and no expression in heart (data not
shown). Exposure for six days showed expression in heart,
no expression in the brain and abundant expression in
placenta as shown in Figure 1. We observed a single tran-
Figure 1
Six day exposure of Human Multi Tissue Northern Blot
(Clontech Cat. #7760-1) probed with EST ym59b11 (with
insert size 2.386 Kb which contains exon 31 and exon 32
(3'UTR) of DLG5) shows a transcript of about 7.2 Kb with
expression in the heart, absence of expression in brain and
abundant expression in placenta.BMC Genomics 2002, 3 http://www.biomedcentral.com/1471-2164/3/6
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script of approximately 7.2 Kb thus, the published se-
quence of the cDNA for the DLG5 gene was incomplete.
Cloning and sequencing of the DLG5 cDNA
On Northern Blot Analysis a single transcript of approxi-
mately 7.2 Kb was observed. Using Race Technique on
Heart cDNA and heart library screening as described
above we characterized the entire cDNA of 7.195 Kb: a
5'UTR from bp 1 to 94, ORF from bp 95–5547 and 3'UTR
from bp 5548–7195. The translation start codon of the
cDNA is at bp 118 in exon 2 and the stop codon is at bp
5545 in exon 32. As multiple clones were sequenced after
RACE, 2 distinct forms were observed: one with a 12 nu-
cleotide deletion in the beginning of exon 4 and the form
without the deletion. The deletion did not result in any
change in the ORF of the gene.
Search for ESTS homologous to the cDNA
Using Search Launcher available on the Molecular Biology
Computational Resources (MBCR) server at Baylor Col-
lege of Medicine (BCM)  [www.mbcr.bcm.tmc.edu]  ho-
mology searches on the new cDNA sequence against
DBEST database identified several ESTs, {Acc. #BF357671
and Acc. #bf336740} which overlap each other and
match the new cDNA
Determining the intron exon boundaries of DLG5
We mapped 31 exons (2–32) of the 7.195 Kb of the cDNA
to a genomic region spanning about 79 Kb. We could not
map 1–94 bp (5'UTR) on to the genomic region. This may
be because none of these BACs are completely sequenced
in Genbank and there are still gaps in the genomic se-
quencing. Attempts at direct BAC walking to place these
nucleotides were unsuccessful, perhaps because these re-
gions of genomic DNA are difficult to sequence due to its
secondary structure. The details of the genomic organiza-
tion of the gene are shown in Table 1 and Figure 2. All but
two of the resulting intron-exon boundaries concur with
the typical splice donor and acceptor motif-GT/AG. The
sequences around each splice site are shown in Table 2.
Determining the functional domains in DLG50
The MAGUK family of proteins [2,10] have characteristic
domains which are present in DLG5: PDZ1 at bp 3763–
4074, PDZ 2 domain 4186–4518 bp, SH3 domain bp
4570–4782 and the GUK domain at bp 4915–5539 (Fig-
ure 2).
Several domains were identified in the novel cDNA using
MOTIF at SEQ WEB. A single repeat unit of the Regulator
of Chromosomal Chromatin (RCC1) domain was detect-
ed starting at bp 4333. RCC1 is a eukaryotic protein that
has seven tandem repeats units which comprise a domain
of 50–60 amino acids. This domain binds to chromatin
and interacts with Ran, a nuclear GTP-binding protein
that stimulates a guanine nucleotide dissociation. Thus,
RCC1 probably plays a role as a gene regulator. Only one
Figure 2
Genomic organization of the gene DLG5 with 32 exons spliced over 79 Kb region. The protein domains are shown with refer-
ence to the exons. Domains not shown here are Regulator of Chromosomal Condensation (RCC1) starting at bp 4333 and the
CAAX domain at bp 5536–5545 of the cDNA.BMC Genomics 2002, 3 http://www.biomedcentral.com/1471-2164/3/6
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repeat unit is present in DLG5 which makes it difficult to
predict whether it also has such gene regulating function.
A prenyl group-binding site (CAAX box) was also detected
starting at 5536 bp. A number of proteins are post transla-
tionally modified by the attachment of either a fresnyl or
a geranyl-geranyl group to a cysteine residue. This modifi-
cation occurs on a cysteine residue, three residues proxi-
mal to the C-terminus with two aliphatic amino acids
separating the cysteine from the C-terminus (hence the
term CAAX box). Certain proteins such as Ras proteins
and the Ras-like protein Rho, nuclear lamins A and B and
some G protein alpha subunits have this modification.
These proteins are involved in intracellular signal trans-
duction. This is another mechanism by which DLG5 may
be involved in intracellular signal transduction. In addi-
tion to these domains there are two leucine zippers start-
ing at base pairs 484 and 505 suggesting protein-protein
interaction.
Exclusion of DLG50 as a candidate for familial atrial fibril-
lation in our family
The exons and flanking intronic sequences of DLG50 were
amplified by PCR and sequenced in four members of the
family, two affected and two normals. There were no mis-
sense or nonsense mutations segregating with the disease
in either the coding regions or splice junctions of this
gene. To exclude a large deletion that might have eluded
amplification from diploid DNA by PCR sequencing was
performed on the haploid cell lines and no mutation was
identified. Thus, DLG50 is excluded as a possible cause of
familial atrial fibrillation in these families.
Utilizing the available partial cDNA sequence, we con-
firmed the localization of DLG5 to the locus for atrial fi-
brillation at 10q22 and subsequently cloned and
sequenced the DLG5 gene which spanned 79 KB. The
available 5.5 KB cDNA sequence was extended by RACE
and confirmed on northern analysis to be about 7.2 KB.
Table 1: Position of the DLG5 exons within the cDNA sequence
EXON START BASE END BASE LENGTH (bp)
29 5 1 5 9 6 7
3 160 325 163
4 326 468 144
5 375 560 184
6 561 816 260
7 817 1131 312
8 1132 1315 185
9 1316 1442 126
10 1443 1576 133
11 1577 1703 128
12 1704 1879 176
13 1880 1983 104
14 1984 2076 93
15 2077 3096 1020
16 3097 3220 124
17 3221 3365 145
18 3366 3478 113
19 3479 3568 90
20 3569 3719 151
21 3720 3882 163
22 3883 4016 134
23 4017 4157 141
24 4158 4341 184
25 4342 4490 149
26 4491 4661 171
27 4662 4858 197
28 4859 5002 144
29 5003 5130 128
30 5131 5240 110
31 5241 5350 110
32 5351 7101 1751BMC Genomics 2002, 3 http://www.biomedcentral.com/1471-2164/3/6
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The genomic structure of the DLG5 was determined to
consist of 32 exons and shown to have ubiquitous human
tissue expression including placenta, heart, skeletal mus-
cle, liver and pancreas, with placenta being the tissue of
strongest expression. Exclusion of a deletion from the
haploid cell lines confirmed the absence of any mutation
and thus, DLG5 was excluded as a cause for the atrial fi-
brillation in these families. Two distinct transcripts of
DLG5 were observed differing by only 12 bp, which
would predict the addition (or deletion) of 4 amino acids,
but would not alter the translation frame of the gene.
The DLG5 gene encodes for a protein that is a member of
the MAGUK (Membrane Associated Guan late Kinase ho-
mologs) family of proteins located in the plasma mem-
brane [2]. MAGUK is a new family of proteins that act as
a molecular scaffold for intracellular signaling pathways
[11]. The MAGUK family of proteins is characterized by
domains that interact with other proteins to create an as-
sembly of large multi-protein complexes [10]. The PDZ
(PSD-95, DLG and ZO-1) domains are the best character-
ized for their binding to the C-terminal region of channels
and transmembrane proteins [11]. Usually each protein
has 1–3 copies of such domains [8,12,13]. The SH3 do-
main (Src homology 3) are present in proteins that couple
transmembrane receptors to signaling molecules [14]. The
presence of this domain in MAGUKs increases their possi-
bilities of interacting with signaling pathways. The GUK
domain shows a high degree of similarity to guanylate ki-
nase enzyme, which converts GMP to GDP using ATP as a
phosphate donor. The dlg-like MAGUKs do not have ki-
nase activity [15]. Furthermore this domain has been
shown to interact with other proteins [16–18]. MAGUKs
function by binding to the transmembrane proteins at the
cytoplasmic side and to other signal transduction proteins
and thus appear to provide the platform for efficient and
specific signal interactions between the different compo-
nents of the signaling pathway. Acting as scaffold pro-
Table 2: Sequence of the intron-exon junctions*
Intron Size (bp) 5' splice donor 3' splice acceptor
2 12236 AGCAGTGTGG/gtgagtacca ccttccacag/GCACTACCGG
3 2359 TTGACAAGAG/gtagtaattgg tctgggccag/GCCCTACCAC
4 689 ACTTCTACCA/gtgagtgagg ggtgtttcag/CACACTCCAC
5 9647 CCAGCAGCAG/gtaggcccag ctgtctccag/GTGTTGAAGC
6 1254 CCCTGAGGAG/gtagggctag tcttgccagg/TTTGAGGCG
7 5958 GCTGCGGCAG/gtaggtgggt ctcccaccag/ATCAAAGACA
8 1698 ACAGCATCCG/gtatggggt cttccaccag/GACACTGTG
9 3040 AGGAGCTCAA/gtaggctcgg ctgttcacag/GGACACTGTG
10 396 GAGGGAGACG/gtaagctgcct gtttttgcag/GAGGATATTG
11 686 GCCGCTTAAG/gtaagagttg cctttctcag/GGTCAATGAC
12 369 GGACAGAAAG/gtagcgggcc tggcttgcag/ACAGTGGCAT
13 4404 GATCGTTGCG/gtaagtctca cctgctctag/ATCAATGGCA
14 2282 CCTCCTGAAG/gtaagggctg ccctgcctag/GTATTCCCTC
15 1064 GTTCCTGGAG/gtatagctga gcatctgcag/GAACAGAAGT
16 429 CCGTCTGTGG/gtgagtcagc ccatttctag/GTACTGTTCC
17 1431 TGCATCCCAG/gtatgtgaag ttttacgcag/TGTCCAGCAC
18 680 GCCCGCCTGG/gtaactgcac ggaacaatag/GTTCTTCGAG
19 305 TCCGAGAGAG/gtaaggactt ctctctgcag/GTTCAGTGTC
20 4187 GAAAGGACAG/gtgagcatgg ttttccttag/GCCTTATGTG
21 157 GTTACTGGAG/gtgagaggga gtttccccag/TTCAACGGCA
22 689 CCCGGTCCAG/gtgagtgcgg ccgcctccag/CTCACACCTG
23 1363 GCAGCTCCAG/gtcagcagac ttcctgaaag/GATTGCGGGA
24 1602 CATCCTGGAG/gtgagttctg tccctggcag/TATGGCAGCC
25 867 TCTACATCAG/gtaccagtgg tgtggtccag/GGCCCTGTAC
26 896 GCAAATATGT/gtaagtgttc tgtgccacag/GATGGACCAA
27 9070 CTCTTTGAAG/gcaagtggct tctccctcag/ATTCGGTGAG
28 262 TGTCCCCTTG/gtaaggggca tg cattg cag/AG GTGATGAA
29 1102 CACAGAAAAG/gtacccaggg cccaccccag/AACCGACACT
30 731 AGCACATCAA/gtaggtaact gtccccacag/GGAGCAGAGA
31 1464 TACTTCACAG/gtaggtgtgc tcttttgcag/GGGTCATCCA
*The capital letters represent exon sequence, the lower case letter the intron sequenceBMC Genomics 2002, 3 http://www.biomedcentral.com/1471-2164/3/6
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teins, these proteins play a pivotal role in creating an
efficient signaling pathway by localizing the signaling
molecules at regions of cell surface preferentially exposed
to the ligand, and by spatially restricting the molecules to
provide specific downstream responses.
The DLG5 gene encodes for 2 PDZ domains, with another
region in the N-terminus having very weak homology to
an additional two PDZ domains. It is notable that the
PDZ domains predicted for the DLG5 protein do not have
the GLGF motif [2], present in most members of the
MAGUK family. This motif helps in the binding of the
MAGUK with the C-terminus of proteins that have the
consensus E (S/T) ×  (V/l) motif [19]. However the studies
on the Drosophila protein InaD, which also has a PDZ do-
main, show that are other targets for the PDZ domain that
do not have the consensus C-terminus binding motif [20].
Thus in DLG5 the PDZ domain may be binding to other
targets that do not require the classic GLGF motif for in-
teraction. Like other members of this family DLG5 also
has one SH3 and GUK domain. In addition it has two leu-
cine zippers and an RCC1 domain that represents other
potential protein-protein interactions.
Previously reported MAGUKs have been studied for these
interactions, and elegant work has shown one of its mem-
bers, p55, to form a ternary complex that links the cy-
toskeleton and the plasma membrane to maintain proper
cell shape [3]. Also there is significant evidence that
MAGUKs are active in protein clustering especially of ion
channels and membrane bound receptors [6]. This inter-
action has been proven by experiments in which DLG5
mutants show loss of clustering of the Shaker channels at
neuromuscular junction [6]. Mammalian PSD-95 is a
MAGUK which binds Kir4.1, an inwardly rectifying K+
channel expressed in glial cells and also clusters it to cell
membranes in vitro [21]. Thus MAGUKs may regulate the
distribution and also the function of transmembrane re-
ceptors and channels.
Conclusions
Given these observations, its pattern of expression in the
human adult heart, we considered it to be an excellent
candidate for the familial atrial fibrillation and evaluated
it in our family by sequencing. We have ruled out func-
tional mutation in the coding region and splice junction
as well as any exon deletion as possible cause of the dis-
ease in this family. This gene remains an interesting can-
didate for other inherited cardiac diseases.
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